InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: To infinity and beyond! post# 203449

Sunday, 11/12/2017 10:28:51 AM

Sunday, November 12, 2017 10:28:51 AM

Post# of 403214
Otezla:
RESULTS: More subjects receiving apremilast 20 mg BID achieved ≥ 75% reduction in Psoriasis Area and Severity Index (PASI-75) vs. placebo (24.4% vs. 10.3%; P = 0.023).


How much did Otezla make this year? Is it one of the only Oral Psoriasis drugs? Those numbers are pretty low....I think the data in Prurisol phase 2a warrant a move to phase 2b with a bar set like that......I'll bet: we can lift that bar bro
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News